( When creative concepts collide unexpe...)Accidental naming
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Accidental naming
When creative concepts collide unexpectedly, this sudden accident incubates a branding process, which can result in a random selection of a weird strategy. That gives birth to an extreme name identity, whereupon a major advertising process kicks in. All things are combined -- shaken, not stirred -- and that's how we refer to today's trendy branding. To avoid a catast......
Full article >>>
'"/>
Source:wistechnology.com By Naseem Javed 07/18/05
Related biology technology :
1. Bruker AXS parent buys affiliate company
2. Bruker AXS to acquire companies, form Microanalysis Group
3. Tech Digest: Bruker AXS; RedPrairie
4. Bruker AXS unveils new X-ray detector
5. Bruker acquires French X-ray software company
6. Bruker AXS names new leadership
7. Bruker AXS launches new products at PITTCON 2004
8. Bruker Participates in Dutch Funded Super Microscope Project
9. Bruker Daltonics and Bruker AXS Announce Merger Agreement
10. Kodak in vivo imaging system: precise coregistration of molecular imaging with anatomical X-ray imaging in animals
11. Use of X-rays to advance wood-decay knowledge leads to honor for Forest Products Lab biologist
Post Your Comments:
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3
[0] AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology[0] ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis[0] AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia[0] Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures
Other Biology Technology:Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hill Press Conference 2Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hill Press Conference 3Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability 2Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability 3Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008 2Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008 3
Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hill Press ConferenceElekta Announces First Two Clinical Sites Using VMAT Cancer Treatment CapabilityDerma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008
Breaking Biology News(10 mins):Rodent smoke screen 2Superior offspring without genetic modification 2Plate-eating good: Université de Montréal professor designs edible tableware 2UT Southwestern receives 2442 million in Recovery Act stimulus funding 10714 1UT Southwestern receives 2442 million in Recovery Act stimulus funding 10714 2UT Southwestern receives 2442 million in Recovery Act stimulus funding 10714 3SEA to conduct expedition dedicated to measuring plastic marine debris in the North Atlantic Ocean 10712 1SEA to conduct expedition dedicated to measuring plastic marine debris in the North Atlantic Ocean 10712 2More pain means real gain in complex regional pain syndrome treatment 10710 1More pain means real gain in complex regional pain syndrome treatment 10710 2
Biology Products:
Mouse Anti-beta-lactoglobulin Monoclonal Antibody, Unconjugated, Clone CD-2 from Cosmo Bio Co., Ltd.Goat Anti-DRAK 2 Polyclonal Antibody, Unconjugated from Novus BiologicalsMouse Anti-Rad17 Monoclonal Antibody, Unconjugated, Clone 1C6/2 from AbcamRabbit Anti-Parathyroid Hormone Receptor 2 (PTHR2) Polyclonal Antibody, Unconjugated from CHEMICON
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |